# Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma

> **NCT04009265** · PHASE3 · RECRUITING · sponsor: **Fujian Medical University Union Hospital** · enrollment: 819 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **COMBINATION_PRODUCT:** adjuvant treatment

## Key facts

- **NCT ID:** NCT04009265
- **Lead sponsor:** Fujian Medical University Union Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-23
- **Primary completion:** 2022-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 819 (ESTIMATED)
- **Last updated:** 2021-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04009265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04009265, "Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04009265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*